A detailed history of Barclays PLC transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Barclays PLC holds 753,737 shares of A stock, worth $101 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
753,737
Previous 753,737 -0.0%
Holding current value
$101 Million
Previous $112 Million -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$125.42 - $148.48 $16 Million - $19 Million
127,723 Added 20.4%
753,737 $112 Million
Q2 2024

Aug 14, 2024

SELL
$129.63 - $154.64 $44.3 Million - $52.9 Million
-341,993 Reduced 35.33%
626,014 $81.2 Million
Q1 2024

May 15, 2024

BUY
$128.12 - $149.31 $21.5 Million - $25 Million
167,627 Added 20.94%
968,007 $141 Million
Q4 2023

Feb 15, 2024

BUY
$101.17 - $139.82 $16.6 Million - $23 Million
164,281 Added 25.83%
800,380 $111 Million
Q3 2023

Nov 07, 2023

BUY
$109.73 - $128.47 $10.7 Million - $12.5 Million
97,241 Added 18.05%
636,099 $71.1 Million
Q2 2023

Aug 03, 2023

BUY
$114.69 - $141.28 $29.8 Million - $36.8 Million
260,186 Added 93.37%
538,858 $64.8 Million
Q1 2023

May 04, 2023

SELL
$131.13 - $159.06 $22.7 Million - $27.6 Million
-173,489 Reduced 38.37%
278,672 $38.6 Million
Q4 2022

Feb 13, 2023

BUY
$125.64 - $157.68 $15.6 Million - $19.6 Million
124,494 Added 37.99%
452,161 $67.7 Million
Q3 2022

Nov 03, 2022

BUY
$115.11 - $142.29 $5.73 Million - $7.08 Million
49,738 Added 17.9%
327,667 $39.8 Million
Q2 2022

Aug 12, 2022

SELL
$112.71 - $135.93 $32.6 Million - $39.3 Million
-288,872 Reduced 50.97%
277,929 $33 Million
Q1 2022

May 16, 2022

SELL
$126.0 - $156.48 $1.73 Million - $2.15 Million
-13,751 Reduced 2.37%
566,801 $75 Million
Q4 2021

Feb 14, 2022

SELL
$147.95 - $164.3 $5 Million - $5.55 Million
-33,762 Reduced 5.5%
580,552 $92.7 Million
Q3 2021

Nov 09, 2021

BUY
$147.58 - $179.28 $14.3 Million - $17.4 Million
96,921 Added 18.73%
614,314 $96.8 Million
Q2 2021

Aug 13, 2021

BUY
$127.69 - $148.81 $12.9 Million - $15 Million
101,089 Added 24.28%
517,393 $76.5 Million
Q1 2021

May 13, 2021

SELL
$114.99 - $130.12 $18.4 Million - $20.8 Million
-159,686 Reduced 27.72%
416,304 $52.9 Million
Q4 2020

Feb 11, 2021

BUY
$100.01 - $119.3 $20.8 Million - $24.8 Million
208,210 Added 56.61%
575,990 $68.2 Million
Q3 2020

Nov 12, 2020

BUY
$88.11 - $103.42 $8.73 Million - $10.2 Million
99,035 Added 36.85%
367,780 $37.1 Million
Q2 2020

Aug 12, 2020

BUY
$68.92 - $91.14 $3.11 Million - $4.12 Million
45,165 Added 20.2%
268,745 $23.7 Million
Q1 2020

May 13, 2020

SELL
$63.37 - $90.13 $17.2 Million - $24.5 Million
-271,975 Reduced 54.88%
223,580 $16 Million
Q4 2019

Feb 10, 2020

BUY
$72.49 - $85.45 $4.7 Million - $5.54 Million
64,860 Added 15.06%
495,555 $42.3 Million
Q3 2019

Nov 14, 2019

SELL
$65.59 - $78.07 $7.28 Million - $8.67 Million
-111,045 Reduced 20.5%
430,695 $33 Million
Q2 2019

Aug 14, 2019

BUY
$66.89 - $81.94 $10.7 Million - $13.1 Million
160,423 Added 42.07%
541,740 $40.5 Million
Q1 2019

May 15, 2019

SELL
$63.27 - $82.0 $12.1 Million - $15.7 Million
-191,263 Reduced 33.4%
381,317 $30.7 Million
Q4 2018

Feb 14, 2019

BUY
$61.13 - $74.67 $6.54 Million - $7.99 Million
107,032 Added 22.99%
572,580 $38.6 Million
Q3 2018

Nov 14, 2018

BUY
$61.25 - $71.13 $3.65 Million - $4.23 Million
59,513 Added 14.66%
465,548 $32.8 Million
Q2 2018

Aug 14, 2018

SELL
$61.14 - $69.55 $22.4 Million - $25.5 Million
-366,758 Reduced 47.46%
406,035 $25.1 Million
Q1 2018

May 15, 2018

SELL
$65.05 - $74.82 $3.5 Million - $4.03 Million
-53,818 Reduced 6.51%
772,793 $51.7 Million
Q4 2017

Feb 14, 2018

BUY
$64.87 - $70.59 $29.4 Million - $32 Million
453,683 Added 121.65%
826,611 $55.4 Million
Q3 2017

Nov 14, 2017

BUY
$58.57 - $66.17 $21.8 Million - $24.7 Million
372,928
372,928 $23.9 Million

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $39.8B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.